Current Clinical Trials for Neuromyelitis Optica

Neuromyelitis optica is a rare autoimmune condition that currently has no orphan drug approved for treatment.

n this video, Michael Levy, MD, of Johns Hopkins Medicine in Baltimore, Maryland, discusses the numerous clinical trials in which his clinic is involved to learn more about managing this condition. 

For more information, click here
Printer Printing...